|
⚲
|
| Keyboard |
| Stephen Rocamboli | |
|---|---|
| Firm | |
| Address | 1214 Research Boulevard, Suite 2010 Hummelstown, PA 17036 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Bobcatbio Inc | 021-540640 | Executive Officer | 5.3 M of 15.0 M |
||
| TFF Pharmaceuticals Inc | 021-509405 | Director | of 1.2 M |
||
| TFF Pharmaceuticals Inc | 021-373611 | Director | 25.9 M of 25.9 M |
||
| TFF Pharmaceuticals Inc | 021-344985 | Director | 8.2 M of 8.2 M |
||
| Advantagene Inc | 021-326482 | Executive Officer | 28.7 M of 28.7 M |
||
| Advantagene Inc | 021-261703 | Executive Officer | 14.2 M of 35.0 M |
||
| Advantagene Inc | 021-253495 | Executive Officer | 2.2 M of 2.5 M |
||
| Foresight Biotherapeutics Inc | 021-206282 | Director | 15.0 M of 15.0 M |
||
| Cutanea Life Sciences Inc | 021-165567 | Director | 0.5 M of 0.5 M |
||
| Foresight Biotherapeutics Inc | 021-163672 | Director | 2.0 M of 2.0 M |
||